Mangoceuticals, Inc. (MGRX)

Mangoceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.07	0.74	0.68	0.02
Cash & Short-Term Investments	0.09	0.74	0.68	0.02
Cash Growth	-92.65%	8.22%	2928.20%	-
Inventory	0.01	0.02	-	-
Prepaid Expenses	-	0.06	0.01	-
Total Current Assets	0.1	0.82	0.69	0.02
Property, Plant & Equipment	0.08	0.22	0.29	-
Other Long-Term Assets	-	0.02	0.02	-
Total Assets	14.79	1.05	1	0.02
Accounts Payable	0.75	0.14	0.03	-
Accrued Expenses	0.01	0.01	0	-
Short-Term Debt	0.19	-	0.17	0.04
Current Portion of Leases	0.07	0.06	0.06	-
Total Current Liabilities	1.39	0.21	0.26	0.04
Long-Term Leases	0.01	0.06	0.13	-
Total Liabilities	1.4	0.28	0.39	0.04
Common Stock	0	0	0	0
Additional Paid-In Capital	31.59	12	2.63	0
Retained Earnings	-17.99	-11.23	-2.02	-0.02
Shareholders' Equity	13.39	0.77	0.61	-0.02
Total Liabilities & Equity	14.79	1.05	1	0.02
Total Debt	0.27	0.13	0.35	0.04
Net Cash (Debt)	-0.18	0.61	0.33	-0.02
Net Cash Growth	-	84.95%	-	-
Net Cash Per Share	-0.11	0.57	0.46	-0.03
Filing Date Shares Outstanding	2.01	1.53	0.89	0.53
Total Common Shares Outstanding	2.01	1.43	0.89	0.53
Working Capital	-1.29	0.61	0.43	-0.02
Book Value Per Share	6.65	0.54	0.69	-0.03
Tangible Book Value	-1.22	0.77	0.61	-0.02
Tangible Book Value Per Share	-0.61	0.54	0.69	-0.03
Machinery	-	0.12	0.12	-

Source: S&P Capital IQ. Standard template. Financial Sources.